The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Update on Lupus Nephritis
Open accessAbstract
SLE is a chronic inflammatory disease that affects the kidneys in about 50% of patients. Lupus nephritis is a major risk factor for overall morbidity and mortality in SLE, and despite potent anti-inflammatory and immunosuppressive therapies still ends in CKD or ESRD for too many patients. This review highlights recent updates in our understanding of disease epidemiology, genetics, pathogenesis, and treatment in an effort to establish a framework for lupus nephritis management that is patient-specific and oriented toward maintaining long-term kidney function in patients with lupus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
Weening, J. J., D’Agati, V. D., Schwartz, M. M., Seshan, S. V., Alpers, C. E., Appel, G. B., Balow, J. E., Bruijn, J. A., Cook, T., Ferrario, F., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000108969.21691.5d · Cited by 2,008
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
Hakkim, A., Fürnrohr, B. G., Amann, K., Laube, B., Abed, U. A., Brinkmann, V., Herrmann, M., Voll, R. E., & Zychlinsky, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909927107 · Cited by 1,469
Rovin, B. H., Furie, R., Latinis, K., Looney, R. J., Fervenza, F. C., Sanchez‐Guerrero, J., Maciuca, R., Zhang, D., Garg, J. P., Brunetta, P., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34359 · Cited by 1,461
Self-citationVillanueva, E., Yalavarthi, S., Berthier, C. C., Hodgin, J. B., Khandpur, R., Lin, A. M., Rubin, C. J., Zhao, W., Olsen, S. H., Klinker, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100450 · Cited by 1,241
Austin, H. A., Klippel, J. H., Balow, J. E., Le Riche, N. G. H., Steinberg, A. D., Plotz, P. H., & Decker, J. L. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603063141004 · Cited by 1,185
Mortality in systemic lupus erythematosus
Bernatsky, S., Boivin, J. ‐., Joseph, L., Manzi, S., Ginzler, E., Gladman, D. D., Urowitz, M., Fortin, P. R., Petri, M., Barr, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21955 · Cited by 1,181
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Appel, G. B., Contreras, G., Dooley, M. A., Ginzler, E. M., Isenberg, D., Jayne, D., Li, L.-S., Mysler, E., Sa[Combining Acute Accent]nchez-Guerrero, J., Solomons, N., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008101028 · Cited by 1,118
Houssiau, F. A., Vasconcelos, C., D'Cruz, D., Sebastiani, G. D., Garrido, E. D. R., Danieli, M. G., Abramovicz, D., Blockmans, D., Mathieu, A., Direskeneli, H., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10461 · Cited by 1,077
Jego, G., Palucka, A. K., Blanck, J.-P., Chalouni, C., Pascual, V., & Banchereau, J. (2003) · Immunity · doi:10.1016/s1074-7613(03)00208-5 · Cited by 1,067
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.9 · Cited by 966
Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus
Pons-Estel, G. J., Alarcón, G. S., Scofield, L., Reinlib, L., & Cooper, G. S. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.10.007 · Cited by 908
Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden
Danchenko, N., Satia, J. A., & Anthony, M. S. (2006) · Lupus · doi:10.1191/0961203306lu2305xx · Cited by 834
Prognostic factors in lupus nephritis
Austin, H. A., Muenz, L. R., Joyce, K. M., Antonovych, T. T., Kullick, M. E., Klippel, J. H., Decker, J. L., & Balow, J. E. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90338-8 · Cited by 803
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
Banchereau, R., Hong, S., Cantarel, B., Baldwin, N., Baisch, J., Edens, M., Cepika, A.-M., Acs, P., Turner, J., Anguiano, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.03.008 · Cited by 731
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
McKinney, E. F., Lee, J. C., Jayne, D. R. W., Lyons, P. A., & Smith, K. G. C. (2015) · Nature · doi:10.1038/nature14468 · Cited by 685 · cited 1×
“Finally, a recent investigation tied concepts important for viral immunity to autoimmunity, providing insights into relapsing autoimmune disease (46), a problem that is particularly relevant to LN.”
BackgroundThe frequency and outcome of lupus nephritis: results from an international inception cohort study
Hanly, J. G., O’Keeffe, A. G., Su, L., Urowitz, M. B., Romero-Diaz, J., Gordon, C., Bae, S.-C., Bernatsky, S., Clarke, A. E., Wallace, D. J., et al. (2016) · Rheumatology · doi:10.1093/rheumatology/kev311 · Cited by 647
Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
Dooley, M. A., Jayne, D., Ginzler, E. M., Isenberg, D., Olsen, N. J., Wofsy, D., Eitner, F., Appel, G. B., Contreras, G., Lisk, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014460 · Cited by 642
Tektonidou, M. G., Dasgupta, A., & Ward, M. M. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39594 · Cited by 582
Houssiau, F. A., Vasconcelos, C., D'Cruz, D., Sebastiani, G. D., de Ramon Garrido, E., Danieli, M. G., Abramovicz, D., Blockmans, D., Cauli, A., Direskeneli, H., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.102533 · Cited by 542
Feldman, C. H., Hiraki, L. T., Liu, J., Fischer, M. A., Solomon, D. H., Alarcón, G. S., Winkelmayer, W. C., & Costenbader, K. H. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37795 · Cited by 487
Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans.
Salmon, J. E., Millard, S., Schachter, L. A., Arnett, F. C., Ginzler, E. M., Gourley, M. F., Ramsey-Goldman, R., Peterson, M. G., & Kimberly, R. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118552 · Cited by 469
Multitarget Therapy for Induction Treatment of Lupus Nephritis: A Randomized Trial
Liu, Z., Zhang, H., Liu, Z., Xing, C., Fu, P., Ni, Z., Chen, J., Lin, H., Liu, F., He, Y., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1030 · Cited by 396
Jakes, R. W., Bae, S., Louthrenoo, W., Mok, C., Navarra, S. V., & Kwon, N. (2012) · Arthritis Care & Research · doi:10.1002/acr.20683 · Cited by 364
Bastian, H. M., Roseman, J. M., Mcgwin, G., Alarcón, G. S., Friedman, A. W., Fessler, B. J., Baethge, B. A., Reveille, J. D., & Lumina Study Group (2002) · Lupus · doi:10.1191/0961203302lu158oa · Cited by 360
C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN
Xiao, H., Dairaghi, D. J., Powers, J. P., Ertl, L. S., Baumgart, T., Wang, Y., Seitz, L. C., Penfold, M. E. T., Gan, L., Hu, P., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013020143 · Cited by 353
Survival analysis and causes of mortality in patients with lupus nephritis
Yap, D. Y. H., Tang, C. S. O., Ma, M. K. M., Lam, M. F., & Chan, T. M. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs073 · Cited by 319
Value of a Complete or Partial Remission in Severe Lupus Nephritis
Chen, Y. E., Korbet, S. M., Katz, R. S., Schwartz, M. M., & Lewis, E. J. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03280807 · Cited by 312
End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1
Freedman, B. I., Langefeld, C. D., Andringa, K. K., Croker, J. A., Williams, A. H., Garner, N. E., Birmingham, D. J., Hebert, L. A., Hicks, P. J., Segal, M. S., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38220 · Cited by 299
Mina, R., & Brunner, H. I. (2010) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2009.12.012 · Cited by 291
The ACCESS Trial Group (2014) · Arthritis & Rheumatology · doi:10.1002/art.38790 · Cited by 288
Dooley, M., Houssiau, F., Aranow, C., D’Cruz, D., Askanase, A., Roth, D., Zhong, Z., Cooper, S., Freimuth, W., & Ginzler, E. (2013) · Lupus · doi:10.1177/0961203312465781 · Cited by 265
Reveille, J. D., Moulds, J. M., Ahn, C. W., Friedman, A., Baethge, B. A., Roseman, J. M., Straaton, K. V., Alarc�n, G. S., & the Lumina Study Group (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199807)41:7<1161::aid-art4>3.0.co;2-k · Cited by 257
Peterson, K. S., Huang, J.-F., Zhu, J., D’Agati, V., Liu, X., Miller, N., Erlander, M. G., Jackson, M. R., & Winchester, R. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19139 · Cited by 251
Predictive power of the second renal biopsy in lupus nephritis: Significance of macrophages
Hill, G. S., Delahousse, M., Nochy, D., Rémy, P., Mignon, F., Méry, J.-P., & Bariéty, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00492.x · Cited by 246
Renal Involvement in Systemic Lupus Erythematosus: A Study of 180 Patients from a Single Center
Du Le Huong, T., Papo, T., Beaufils, H., Wechsler, B., Blétry, O., Baumelou, A., Godeau, P., & Piette, J.-C. (1999) · Medicine · doi:10.1097/00005792-199905000-00002 · Cited by 233
Costenbader, K. H., Desai, A., Alarcón, G. S., Hiraki, L. T., Shaykevich, T., Brookhart, M. A., Massarotti, E., Lu, B., Solomon, D. H., & Winkelmayer, W. C. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30293 · Cited by 230
Austin, H. A., Boumpas, D. T., Vaughan, E. M., & Balow, J. E. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.9.1620 · Cited by 229
Mok, C. C., Ying, K. Y., Yim, C. W., Siu, Y. P., Tong, K. H., To, C. H., & Ng, W. L. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206456 · Cited by 220
The type I interferon system in the development of lupus
Rönnblom, L., Alm, G. V., & Eloranta, M.-L. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.009 · Cited by 206
Outcomes in African Americans and Hispanics with lupus nephritis
Contreras, G., Lenz, O., Pardo, V., Borja, E., Cely, C., Iqbal, K., Nahar, N., de La Cuesta, C., Hurtado, A., Fornoni, A., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000243 · Cited by 202
Fiehn, C., Hajjar, Y., Mueller, K., Waldherr, R., Ho, A. D., & Andrassy, K. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.5.435 · Cited by 197
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
On behalf of the BRAVO Study Group, Vollmer, T. L., Sorensen, P. S., Selmaj, K., Zipp, F., Havrdova, E., Cohen, J. A., Sasson, N., Gilgun-Sherki, Y., & Arnold, D. L. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7264-4 · Cited by 194
Gender Differences in the Pathogenesis and Outcome of Lupus and of Lupus Nephritis
Schwartzman-Morris, J., & Putterman, C. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/604892 · Cited by 193
Role of early repeated renal biopsies in lupus nephritis
Zickert, A., Sundelin, B., Svenungsson, E., & Gunnarsson, I. (2014) · Lupus Science & Medicine · doi:10.1136/lupus-2014-000018 · Cited by 146
Clinical–Morphological Features and Outcomes of Lupus Podocytopathy
Hu, W., Chen, Y., Wang, S., Chen, H., Liu, Z., Zeng, C., Zhang, H., & Liu, Z. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06720615 · Cited by 144
Lupus nephritis susceptibility loci in women with systemic lupus erythematosus.
Chung, S. A., Brown, E., Williams, A. H., Ramos, P. S., Berthier, C., Bhangale, T., Alarconriquelme, M., Behrens, T., Criswell, L., Graham, D., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050446 · Cited by 130
Tsuda, K., Yamanaka, K., Kitagawa, H., Akeda, T., Naka, M., Niwa, K., Nakanishi, T., Kakeda, M., Gabazza, E. C., & Mizutani, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031465 · Cited by 126
Lerang, K., Gilboe, I.-M., Thelle, D. S., & Gran, J. T. (2014) · Lupus · doi:10.1177/0961203314551083 · Cited by 118
Raffler, J., Friedrich, N., Arnold, M., Kacprowski, T., Rueedi, R., Altmaier, E., Bergmann, S., Budde, K., Gieger, C., Homuth, G., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005487 · Cited by 112
Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: a meta-analysis
Niu, Z., Zhang, P., & Tong, Y. (2014) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12528 · Cited by 105
Current and Emerging Therapies for Lupus Nephritis
Parikh, S. V., & Rovin, B. H. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016040415 · Cited by 101
Self-citationLupus in Latin-American patients: lessons from the GLADEL cohort
Pons‐Estel, G., Catoggio, L. J., Cardiel, M. H., Bonfá, E., Caeiro, F., Sato, E. I., Massardo, L., Molina, J. F., Toledano, M. G., Barile-Fabris, L. A., et al. (2015) · Lupus · doi:10.1177/0961203314567753 · Cited by 92
Miyadera, H., & Tokunaga, K. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2015.100 · Cited by 87
Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA
Miyadera, H., Ohashi, J., Lernmark, Å., Kitamura, T., & Tokunaga, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74961 · Cited by 86
Multiethnic lupus cohorts: What have they taught us?
Alarcón, G. S. (2010) · Reumatología Clínica · doi:10.1016/j.reuma.2010.11.001 · Cited by 79
Burgos, P. I., McGwin, G., Pons‐Estel, G., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.131482 · Cited by 76
Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis
Lin, C. P., Adrianto, I., Lessard, C. J., Kelly, J. A., Kaufman, K. M., Guthridge, J. M., Freedman, B. I., Anaya, J., Alarcón-Riquelme, M. E., Networks, O. B. O. T. B. A. G., et al. (2011) · Genes and Immunity · doi:10.1038/gene.2011.82 · Cited by 72
Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare
Birmingham, D. J., Bitter, J. E., Ndukwe, E. G., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03990415 · Cited by 71
Lourenço, E. V., Wong, M., Hahn, B. H., Palma-Diaz, M., & Skaggs, B. J. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38259 · Cited by 65
Hopkinson, N., Jenkinson, C., Muir, K. R., Doherty, M., & Powell, R. J. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.2.116 · Cited by 65
Patient Characteristics and Outcomes by GN Subtype in ESRD
O'Shaughnessy, M. M., Montez‐Rath, M. E., Lafayette, R. A., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11261114 · Cited by 64
Pagni, F., Galimberti, S., Goffredo, P., Basciu, M., Malachina, S., Pilla, D. M., Galbiati, E., & Ferrario, F. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft272 · Cited by 61
Bastian, H. M., Alarcón, G. S., Roseman, J. M., McGwin, G., Vilá, L. M., Fessler, B. J., Reveille, J. D., & for the LUMINA study group (2006) · Rheumatology · doi:10.1093/rheumatology/kel347 · Cited by 59
Dall’Era, M., Levesque, V., Solomons, N., Truman, M., & Wofsy, D. (2015) · Lupus Science & Medicine · doi:10.1136/lupus-2015-000089 · Cited by 56
Survival Disparity of African American Versus Non–African American Patients With ESRD Due to SLE
Nee, R., Martinez-Osorio, J., Yuan, C. M., Little, D. J., Watson, M. A., Agodoa, L. Y. C., & Abbott, K. C. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.04.011 · Cited by 55
Pang, Y., Yang, X.-W., Song, Y., Yu, F., & Zhao, M. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.07.004 · Cited by 53
Bethunaickan, R., Berthier, C. C., Zhang, W., Kretzler, M., & Davidson, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077489 · Cited by 53
Value of repeat biopsy in lupus nephritis flares
Greloni, G. C., Scolnik, M., Marín, J., Lancioni, E., Quiroz, C. M., Zacariaz, J., Niveyro, P. X. D. L. I., Christiansen, S., Pierangelo, M. A., Varela, C. F., et al. (2014) · Lupus Science & Medicine · doi:10.1136/lupus-2013-000004 · Cited by 52
Parikh, S. V., Malvar, A., Song, H., Alberton, V. G., Lococo, B., Vance, J., Zhang, J., Yu, L., & Rovin, B. H. (2015) · Lupus Science & Medicine · doi:10.1136/lupus-2015-000112 · Cited by 48
Self-citationGallagher, K. M. E., Lauder, S. N., Rees, I. W., Gallimore, A., & Godkin, A. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801607 · Cited by 47
The sodium‐dependent glucose cotransporter SLC5A11 as an autoimmune modifier gene in SLE
Tsai, L.-J., Hsiao, S.-H., Tsai, L.-M., Lin, C., Tsai, J., Liou, D. ‐., & Lan, J. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2007.00975.x · Cited by 41
Complement Regulation in Renal Disease Models
Naik, A. S., Sharma, S., & Quigg, R. J. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.008 · Cited by 34
The Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis (SIMPL) Pilot Trial
Galbraith, L., Manns, B., Hemmelgarn, B. R., & Walsh, M. W. (2014) · Canadian Journal of Kidney Health and Disease · doi:10.1186/s40697-014-0030-9 · Cited by 33
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Kiriakidou, M., & Ching, C. L. (2020) · Annals of Internal Medicine · doi:10.7326/aitc202006020 · Cited by 821
Regulatory mechanisms of PD-1/PD-L1 in cancers
Lin, X., Kang, K., Chen, P., Zeng, Z., Li, G., Xiong, W., Yi, M., & Xiang, B. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02023-w · Cited by 784
Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal
Azzouz, D., Omarbekova, A., Heguy, A., Schwudke, D., Gisch, N., Rovin, B. H., Caricchio, R., Buyon, J. P., Alekseyenko, A. V., & Silverman, G. J. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214856 · Cited by 436
Self-citationKiriakidou, M. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-7-201310010-01004 · Cited by 333
Metadata
- Authors
- Almaani, S., Meara, A., & Rovin, B. H.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2016-11-07
- Volume
- 12
- Issue
- 5
- Pages
- 825-835
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- OpenAlex
- W2553726688
- Cited by
- 930
- References
- 73
- FWCI
- 46.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.